Position in GLUE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$900,941
+$288,524 QoQ
Shares Held
37,229
0.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#100
of 193 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Round Rock Advisors LLC holds $3,162,164 across 6 Biotechnology names. GLUE ranks #2 (28.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBYI |
Puma Biotechnology, Inc.
|
128,912 | $1,045,476 | |
| 2 | GLUE |
Monte Rosa Therapeutics, Inc.
This page
|
37,229 | $900,941 | |
| 3 | FENC |
Fennec Pharmaceuticals Inc.
|
48,683 | $523,342 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
5,362 | $419,683 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
4,964 | $272,722 | |
| 6 | 32,438 | $0 |
All Filings in GLUE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $900,941 | 37,229 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $612,417 | 37,229 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||